Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Elicio Therapeutics, Inc.
Report date August 31, 2021 · Filed August 31, 2021
Section 16 reporting ended · disclosed 2021-08-31. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,740,978 |
Reported balance
After 2021-08-31 transaction · row 1
1 source rowRow 1 · 2021-08-31 · Other · Disposed 913,659 · Balance 2,740,978 F1: EISA-ABC LLC distributed these shares to its then member, Elisha Goldberg, which represented his pro rata ownership interest in the shares held by EISA-ABC LLC, for no consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: EISA-ABC LLC distributed these shares to its then member, Elisha Goldberg, which represented his pro rata ownership interest in the shares held by EISA-ABC LLC, for no consideration.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 31, 2021 Filed Aug 31, 2021 19:32 UTC | Elicio Therapeutics, Inc. ANGN · Entity 299 | OtherCommon Stock | 913,659 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-054163 · doc4.xml · nonDerivative · entry 1 EISA-ABC LLC · CIK 0001878914 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740,978 F1 · kind: EISA-ABC LLC distributed these shares to its then member, Elisha Goldberg, which represented his pro rata ownership interest in the shares held by EISA-ABC LLC, for no consideration. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.